Association between protease inhibitor use and increased cardiovascular risk in patients infected with human immunodeficiency virus: a systematic review.
about
Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDSHIV infection.Capsaicin blocks HIV protease inhibitor ritonavir-induced vascular dysfunction in porcine pulmonary arteriesPreventive health care among HIV positive women in a Utah HIV/AIDS clinic: a retrospective cohort studyCardiovascular disease in HIV patients: from bench to bedside and backwards.A pathophysiological approach to antiretroviral therapy.Cardiovascular disease and toxicities related to HIV infection and its therapies.Nelfinavir suppresses insulin signaling and nitric oxide production by human aortic endothelial cells: protective effects of thiazolidinedionesTypes of Myocardial Infarction Among Human Immunodeficiency Virus-Infected Individuals in the United States.Power spectral analysis of heart rate variability in HIV-infected and AIDS patients.Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins.The development of metabolic risk factors after the initiation of the second line anti- retroviral therapy.Impact of short-term antiretroviral therapy (START) on some fibrinolytic markers in HIV-infected Nigerian adults: preliminary findings from the START study.A review of drug-drug interactions in older HIV-infected patients.Lipid-lowering and anti-inflammatory effects of tetradecylthioacetic acid in HIV-infected patients on highly active antiretroviral therapy.Relative effects of insulin resistance and protease inhibitor treatment on lipid and lipoprotein metabolism in HIV-infected patients.Increased platelet reactivity in HIV-1-infected patients receiving abacavir-containing antiretroviral therapy
P2860
Q24792952-9EFE02DD-78D5-483A-93DD-8D50B151BD60Q34011172-F4774240-5B74-4001-BEE9-7E94F45ACA38Q34100679-91D9AAC7-25A1-47A2-A7D3-CC902FBD2315Q35110010-2DC9B317-E373-4070-A514-5D7A3AD05ED2Q35203971-6BE2755E-B994-412A-861E-179C6577E6E1Q35917460-A7E96BDB-1B9E-4D56-B814-4B0F060D55C3Q36299974-42A92F57-7855-4A85-8729-92BA1B362263Q36701580-5831D226-1D94-497C-8255-CD434A1FD843Q39041099-A94C27DB-3A00-4AC7-8CB5-EBEDC5B03B7EQ39743645-1B3EA1CF-0EA1-4288-9532-3C544A889E5AQ40389936-B1EF34E0-4457-4EDF-A241-9B91FFBCD026Q41437025-C969908D-3719-4532-875E-444E9A8B1D9EQ41836230-108686FD-A8E7-4E9F-9090-671DFE7998F4Q41996857-9BA39F04-272C-4BCD-88AA-CFC1CCD94394Q45097812-92DCB40A-7039-4E7D-BEB5-3E76D39B2FA3Q45245265-01EE5315-FE2D-4459-94B0-72502EC6FB51Q57098021-D188CAE0-EAFF-4669-BDC3-7C81030F7135
P2860
Association between protease inhibitor use and increased cardiovascular risk in patients infected with human immunodeficiency virus: a systematic review.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Association between protease i ...... cy virus: a systematic review.
@ast
Association between protease i ...... cy virus: a systematic review.
@en
type
label
Association between protease i ...... cy virus: a systematic review.
@ast
Association between protease i ...... cy virus: a systematic review.
@en
prefLabel
Association between protease i ...... cy virus: a systematic review.
@ast
Association between protease i ...... cy virus: a systematic review.
@en
P2093
P356
P1476
Association between protease i ...... ncy virus: a systematic review
@en
P2093
Daniel Aguilar
David C Rhew
Myriam Bernal
Uchenna Iloeje
P304
P356
10.1086/378064
P407
P577
2003-09-12T00:00:00Z